Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2000
04/13/2000CA2344995A1 Cancer associated antigens and uses therefor
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression
04/13/2000CA2344613A1 Compositions and methods for inhibiting angiogenesis
04/13/2000CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000CA2341351A1 Alpha-2/delta gene
04/13/2000CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy
04/12/2000EP0992587A2 High affinity IP3-binding polypeptide
04/12/2000EP0992579A1 Stem cell factor
04/12/2000EP0991771A2 Lentivirus based vector and vector system
04/12/2000EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof
04/12/2000EP0991759A1 Ntn-2 member of tnf ligand family
04/12/2000EP0991758A1 Smad6 and uses thereof
04/12/2000EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
04/12/2000EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor
04/12/2000EP0991425A1 Pro
04/12/2000EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
04/12/2000EP0991321A1 Tolerance to natural antibody antigens
04/12/2000EP0991319A2 Treatment for diabetes
04/12/2000EP0814838A4 Antigen presenting system and methods for activation of t-cells
04/12/2000CN1250484A Diagnosis and treatment of glaucoma
04/12/2000CN1250480A Eukaryotic gene expression cassette and uses thereof
04/12/2000CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family
04/11/2000US6048965 Polypeptide that controls the premature degradation of transcripts
04/11/2000US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
04/11/2000US6048837 Dietetics
04/11/2000US6048729 Animal transfected clonal cells for the expression of therapeutic products
04/11/2000US6048725 Genetically engineered cancer cell line; for producing recombinant viral vectors and packaging cells
04/11/2000US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective
04/11/2000US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents
04/11/2000US6048711 Human G-protein coupled receptor polynucleotides
04/11/2000US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders
04/11/2000US6048702 Antibody which specifically binds to a oncogene modulating peptide; for the diagnosis and treatment of breast, prostate, or liver cancer; anticarcinogenic agents; antitumor agents
04/11/2000US6048525 Implanting hematopoietic cells comprising t-lymphocyte with dna sequence that expresses thymidine kinase gene; administering ganciclovir or acyclovir; treating graft versus host disease
04/11/2000US6048524 In vivo production and delivery of erythropoietin for gene therapy
04/06/2000WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers
04/06/2000WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000WO2000018920A2 Tmof receptor and uses thereof
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression
04/06/2000WO2000018903A2 Inducible genetic suppression of cellular excitability
04/06/2000WO2000018902A1 Method of screening for large offspring syndrome
04/06/2000WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
04/06/2000WO2000018894A1 A BIOLOGICALLY ACTIVE ALTERNATIVE FORM OF THE IKKα IλB KINASE
04/06/2000WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells
04/06/2000WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000WO2000018799A1 Artemin, a novel neurotrophic factor
04/06/2000WO2000018797A1 Map
04/06/2000WO2000018796A2 Secretory protein- zsig48
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018781A1 Antisense modulation of survivin expression
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018437A1 Tie2 antagonist antibodies
04/06/2000WO2000018434A1 Mutant cholera holotoxin as an adjuvant
04/06/2000WO2000018426A1 Apoptosis inducers
04/06/2000WO2000004051A9 Growth differentiation factor promoter and uses therefor
04/06/2000WO2000001835A3 Targeted integration into chromosomes using retroviral vectors
04/06/2000WO1999064585A3 Novel angiotensin receptor, production and use thereof
04/06/2000WO1999064582A3 High-throughput screening of gene function using libraries for functional genomics applications
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061057A3 Molecules targeting cd40 and tumor cells
04/06/2000WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
04/06/2000WO1999055564A9 Materials and methods for gene therapy
04/06/2000WO1999055132A3 Generation of packaging system for human recombinant adenoviral vectors
04/06/2000WO1999054706A3 Method of treating interstitial cystitis with recombinant hb-egf
04/06/2000WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules
04/06/2000WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses
04/06/2000WO1999046284A3 Molecules that home to various selected organs or tissues
04/06/2000CA2344712A1 Secretory protein- zsig48
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000CA2344578A1 Polistinae venom phospholipase
04/06/2000CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000CA2344104A1 Method of screening for large offspring syndrome
04/06/2000CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers
04/06/2000CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000CA2343927A1 Artemin, a novel neurotrophic factor
04/06/2000CA2343922A1 Use of specific hybrid promoters for controlling tissue expression
04/06/2000CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000CA2341363A1 Tmof receptor and uses thereof
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/05/2000EP0990046A2 Neuronal stem cell gene
04/05/2000EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
04/05/2000EP0990034A1 Anti-gpiib/iiia recombinant antibodies
04/05/2000EP0990031A2 Tumor necrosis factor receptor 5
04/05/2000EP0990030A1 Transcriptional activators with graded transactivation potential
04/05/2000EP0989863A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow
04/05/2000EP0989861A1 Immunogenic compositions for induction of anti-tumor immunity
04/05/2000EP0989859A1 Cns neuroregenerative compositions and methods of use
04/05/2000EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000EP0989849A2 Therapeutic nanospheres
04/05/2000EP0795007A4 Bioengineered human blood cells
04/05/2000EP0792369B1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy
04/05/2000EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
1 ... 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 ... 870